Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics for Lower Limb Skin Excisions
NCT03357419Withdrawn
- Sponsor
- Rambam Health Care Campus
- Start
- Mar 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cefalexin in surgical site infection (SSI) (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Absence of infection after 1 month follow-up. Planned start Mar 2021; status: withdrawn.
02
Drugs
cefalexin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03357419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03357419.